[go: up one dir, main page]

MX2020003752A - Composición tópica y método para tratar y prevenir la dermatitis atópica e infecciones relacionadas con la biopelícula bacteriana. - Google Patents

Composición tópica y método para tratar y prevenir la dermatitis atópica e infecciones relacionadas con la biopelícula bacteriana.

Info

Publication number
MX2020003752A
MX2020003752A MX2020003752A MX2020003752A MX2020003752A MX 2020003752 A MX2020003752 A MX 2020003752A MX 2020003752 A MX2020003752 A MX 2020003752A MX 2020003752 A MX2020003752 A MX 2020003752A MX 2020003752 A MX2020003752 A MX 2020003752A
Authority
MX
Mexico
Prior art keywords
treat
atopic dermatitis
topical composition
bacterial biofilm
infections related
Prior art date
Application number
MX2020003752A
Other languages
English (en)
Other versions
MX393583B (es
Inventor
Sandra Noe
Manon Rossano
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MX2020003752A publication Critical patent/MX2020003752A/es
Publication of MX393583B publication Critical patent/MX393583B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Una nanoemulsión que contiene una sal de amonio cuaternario con al menos una cadena de veinte carbonos es eficaz para prevenir el crecimiento de biopelículas.
MX2020003752A 2017-09-26 2018-09-24 Composición tópica y método para tratar y prevenir la dermatitis atópica e infecciones relacionadas con la biopelícula bacteriana. MX393583B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762563114P 2017-09-26 2017-09-26
PCT/IB2018/057369 WO2019064162A1 (en) 2017-09-26 2018-09-24 TOPICAL COMPOSITION AND METHOD FOR TREATING AND PREVENTING ATOPIC DERMATITIS AND INFECTIONS ASSOCIATED WITH BACTERIAL BIOFILM

Publications (2)

Publication Number Publication Date
MX2020003752A true MX2020003752A (es) 2022-06-30
MX393583B MX393583B (es) 2025-03-24

Family

ID=63840888

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020003752A MX393583B (es) 2017-09-26 2018-09-24 Composición tópica y método para tratar y prevenir la dermatitis atópica e infecciones relacionadas con la biopelícula bacteriana.

Country Status (8)

Country Link
US (1) US11241385B2 (es)
EP (1) EP3687497B1 (es)
KR (1) KR102658501B1 (es)
CN (1) CN111372565A (es)
AU (1) AU2018342767B2 (es)
CA (1) CA3077125A1 (es)
MX (1) MX393583B (es)
WO (1) WO2019064162A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113413331B (zh) * 2020-12-30 2022-09-13 厦门中翎易优创科技有限公司 祛痘组合物及其制剂和用途
WO2024263589A1 (en) * 2023-06-20 2024-12-26 Topaz Biosciences, Inc. Recombinant cell wall hydrolases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389418A (en) * 1981-02-25 1983-06-21 S. C. Johnson & Son, Inc. Skin care composition
US5885596A (en) * 1997-07-23 1999-03-23 Bristol-Myers Squibb Company Methods and compositions for fine lines and/or wrinkles
US6559189B2 (en) 1999-04-28 2003-05-06 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6616922B2 (en) * 2001-03-27 2003-09-09 The Dial Corporation Antibacterial compositions
US20040115159A1 (en) * 2002-03-29 2004-06-17 Tadlock Charles C Novel nanoemulsions
US7268165B2 (en) * 2004-08-20 2007-09-11 Steris Inc. Enhanced activity alcohol-based antimicrobial compositions
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US8226965B2 (en) * 2008-04-25 2012-07-24 Nanobio Corporation Methods of treating fungal, yeast and mold infections
EP2391342A2 (en) * 2009-01-28 2011-12-07 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof

Also Published As

Publication number Publication date
AU2018342767A1 (en) 2020-04-09
US11241385B2 (en) 2022-02-08
RU2020114436A (ru) 2021-10-27
MX393583B (es) 2025-03-24
EP3687497A1 (en) 2020-08-05
BR112020005802A8 (pt) 2022-07-26
BR112020005802A2 (pt) 2020-09-24
AU2018342767B2 (en) 2023-10-12
CN111372565A (zh) 2020-07-03
EP3687497B1 (en) 2023-06-28
WO2019064162A1 (en) 2019-04-04
KR20200058504A (ko) 2020-05-27
KR102658501B1 (ko) 2024-04-19
RU2020114436A3 (es) 2022-02-15
EP3687497C0 (en) 2023-06-28
CA3077125A1 (en) 2019-04-04
US20190091148A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
ES2838803T3 (es) Método para reducir la producción total de gas y/o la producción de metano en un animal rumiante
AR090186A1 (es) Control de microorganismos fitopatogenicos con pseudomonas sp. y sustancias y composiciones derivadas de las mismas
CO2017007694A2 (es) Composiciones de bacillus licheniformis rti184 para beneficiar el crecimiento de plantas
CO2018003168A2 (es) Moduladores de la expresión de kras
MX2016009898A (es) Tratamientos para acne resistente.
CO2022000278A2 (es) Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella
AR101462A1 (es) Composiciones de esporas bacterianas para uso industrial
CL2013003638A1 (es) Compuestos inhibidores de metaloenzimas; composición que comprende dichos compuestos; uso de la composición para tratar o prevenir una enfermedad asociada a metaloenzimas en plantas; uso para inhibir metaloenzimas en microorganismos y tratar un trastorno fúngico en plantas.
UY36332A (es) Composiciones de bacillus pumilus rt1279 y metodos de uso para benefficiar el crecimiento de las plantas
CL2015003120A1 (es) Cepas bacterianas que poseen actividad antimicrobiana y composiciones de control biológico que las contienen
MX385401B (es) Composiciones que contienen lipo-quitooligosacarido y microorganismo para potenciar el crecimiento de las plantas.
CL2015002744A1 (es) Alimento para peces que comprende azadiractina, útil para el tratamiento y/o prevención de infecciones y/o infestaciones parasitarias, particularmente contra el piojo de mar lepeophtherius salmonis.
ECSP19072372A (es) Moduladores de la expresión de pcsk9
CL2020002192A1 (es) Método para mejorar el rendimiento de la planta.
CL2019000872A1 (es) Composición edulcorante con una mejor calidad del sabor que comprende alulosa y sal, y el método para mejorar la calidad del sabor de la alulosa usando sal.
AR107886A1 (es) Composiciones para el tratamiento del cabello
MX2021005526A (es) Una composicion antimicrobiana para inhibir selectivamente el crecimiento de la bacteria p. acnes.
MX393266B (es) Composiciónpara usarse en terapia de microbiota
AR100407A1 (es) Aplicaciones volátiles contra patógenos
CL2017000873A1 (es) Composiciones y métodos para mejorar la movilidad o actividad o tratar la fragilidad
MX2020003752A (es) Composición tópica y método para tratar y prevenir la dermatitis atópica e infecciones relacionadas con la biopelícula bacteriana.
AR106117A1 (es) Método de concentración de proteína en polvo de grano
MX2017009079A (es) Composiciones antimicrobianas solidas con solubilidad mejorada.
BR112018005863A2 (pt) endófitos de brachiaria e métodos relacionados
MX2017012895A (es) Composicion veterinaria de extracto de algas marinas y andrographis sp, util para tratar infeccion en peces.